Marksans Pharma Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "USFDA approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx)".
Press Release Apr 01 2026
Earlier from Marksans Pharma
- Press Release Feb 05 2026
- Press Release Nov 20 2025
- Press Release Nov 19 2025
- Press Release Nov 17 2025